181 evolution "https:" "https:" "https:" "https:" "https:" "https:" "U.S" positions at King's College London
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
development fellowships, with eligibility for an open‑ended position at King’s upon securing such an award. About the role To be successful in this role you need to be able to show a body of research outputs
-
-omics, radiology images, and clinical text, are demonstrating exceptional performance in drug discovery and clinical tasks. Yet their development is hindered by data access, fragmentation, harmonisation
-
development and implementation of compliance strategies tailored to the diverse needs of the campus environment. Promote a culture of safety, accountability, and continuous improvement within the engineering
-
: The Build Director will oversee the design, development and implementation of software applications within the university. This role is crucial in ensuring that the University's applications support Student
-
31st May 2027 with a possibility of an extension. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat
-
assessments and at each stage of development. We aim for a design-first approach, in support of our belief that digital tools and methods should be both instinctively usable and elegant. We are a small team
-
in health and disease and apply this knowledge to the development of new and innovative clinical practise, alongside providing a rigorous academic programme for students. About the role Applications
-
development. This entitlement, from the Concordat to Support the Career Development of Researchers , applies to Postdocs, Research Assistants, Research and Teaching Technicians, Teaching Fellows and AEP
-
(Projects) within the Early Career Researcher Institute, you will play a vital role in delivering high‑quality learning, development and support activities that empower Imperial’s early career researchers
-
for helping to continue the successful delivery and future development of ongoing epilepsy research projects funded by the UK Epilepsy Research Institute, Medical Research Council and Angelini Pharma